Catalyst Wire Dossier Catalyst Wire Dossier

PRGF-Endoret Eye Drops

plasma-rich in growth factors eye drops · Biotechnology Institute IMASD
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRGF-Endoret Eye Drops, covering 2025-02-06 to 2025-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis [Phase 4]

See pricing